Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 91.02M P/E - EPS this Y 20.20% Ern Qtrly Grth -
Income -43.11M Forward P/E -1.42 EPS next Y 6.10% 50D Avg Chg 2.00%
Sales 9.57M PEG - EPS past 5Y - 200D Avg Chg 15.00%
Dividend N/A Price/Book 0.84 EPS next 5Y - 52W High Chg -36.00%
Recommedations 2.60 Quick Ratio 4.88 Shares Outstanding 41.30M 52W Low Chg 140.00%
Insider Own 7.73% ROA -29.46% Shares Float 24.89M Beta 2.41
Inst Own 48.64% ROE -55.37% Shares Shorted/Prior 248.99K/205.43K Price 2.29
Gross Margin - Profit Margin - Avg. Volume 138,196 Target Price 2.50
Oper. Margin -623.35% Earnings Date Nov 11 Volume 75,018 Change 1.33%
About Spruce Biosciences, Inc.

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. Spruce Biosciences, Inc. has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize tildacerfont for the treatment of CAH in Japan. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Spruce Biosciences, Inc. News
11/14/24 Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/12/24 Spruce Biosciences Reports Q3 2024 Earnings and Updates
11/11/24 Spruce Biosciences, Inc. (SPRB) Reports Q3 Loss, Lags Revenue Estimates
11/11/24 Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
10/28/24 Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference
09/03/24 Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/12/24 Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates
08/12/24 Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
06/24/24 Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion
06/06/24 Spruce Biosciences Recognized as a Bay Area Best Place to Work
06/04/24 Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
06/04/24 Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
06/03/24 Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
05/23/24 Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
05/22/24 Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
05/13/24 Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
05/13/24 Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
05/01/24 Spruce Biosciences to Participate in May Investor Conferences
04/30/24 Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
04/22/24 Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
SPRB Chatroom

User Image lqqkerinsiderDOTcom Posted - 21 minutes from now

$SPRB Haven't sold a single share. Does that make me bullish or... https://youtu.be/lp5RBIPtwP0?si=2mKbjpPKQdV8wIHH

User Image Monsters_of_Swing Posted - 1 hour ago

$SPRB 6 trading days til December

User Image 49829910w Posted - 3 hours ago

$SPRB Yup, shorts looking to hit stop losses, buy and cover cheapies, plus let the penny flippers stagnate the stock and regret not holding.

User Image lqqkerinsiderDOTcom Posted - 4 hours ago

$SPRB I still love this little booger!

User Image lucky9150 Posted - 6 hours ago

$SPRB , longs don't put stop loss limit. Instead, put the sell limit at your desired price so shorts do not get your shares for shorting.

User Image Biomechanika Posted - 6 hours ago

$SPRB Started a position here. Might buy more if drops. Not much space for downside, trades at 33% of cash level which is a joke and upcoming topline data in december. Decent amount cash at hand, no debt. Aiming for $2.

User Image RookieTrader500 Posted - 7 hours ago

$SPRB great market conditions for them to release positive news if they wanted.

User Image lucky9150 Posted - 22 hours ago

$SPRB , $ 5 with favorable data

User Image lqqkerinsiderDOTcom Posted - 23 hours ago

$SPRB $2 dolla, make you holla.

User Image Monsters_of_Swing Posted - 1 day ago

$SPRB fair value $2.00-$2.50

User Image lucky9150 Posted - 1 day ago

$SPRB , check out March 21st expiration 0.50 calls. The volume is great.

User Image doqmental2023 Posted - 1 day ago

$SPRB dont be late. Buy now.

User Image Dexter_The_Bull Posted - 1 day ago

$SPRB Good

User Image lucky9150 Posted - 1 day ago

$SPRB , 15th December my guess......

User Image lucky9150 Posted - 1 day ago

$SPRB , not much sellers left. I still believe one day before data drops, mm will try to attack stop losses before final take off.

User Image Monsters_of_Swing Posted - 1 day ago

$SPRB data before December 20

User Image lucky9150 Posted - 2 days ago

$SPRB , split it....

User Image Biomechanika Posted - 2 days ago

$SPRB Might buy dec 20 calls and or shares.

User Image MrAnonymously Posted - 2 days ago

$SPRB đŸ›’

User Image Core366 Posted - 2 days ago

$SPRB Feels just like bngo when the penny flippers and scalpers were in and out until...boom. These binary plays are always fun.

User Image Bobby_J_Bomb Posted - 2 days ago

$XBI $SPRB $VTGN $VSTM $ONCT https://finance.yahoo.com/news/healthcare-executives-expect-more-ipos-141704801.html

User Image SQUEAKSBANDIT Posted - 2 days ago

$SPRB this could easily spill into jan if so dec 20th on could get interesting a full 5% of the float is tied up in a single contract, this is rare if these expire worthless what does the guy who wrote em do? assuming they are covered he/she/they may not want to hold that much common they could decide to dump on the open market could see some fireworks

User Image lucky9150 Posted - 2 days ago

$SPRB , after market up 0.02 cents not bad.

User Image lucky9150 Posted - 2 days ago

$SPRB , My guess is we will get get data by 15th December late by late. It will be awesome data, too, after listing the 11th November interview of the CEO. Finally, he sounds very positive and optimistic.

User Image Bobby_J_Bomb Posted - 3 days ago

$SPRB Crazy how markets shift. It would've been insane to think even 2 years ago that a company trading at 1/3 of cash value, with no debt and 2 registrational studies in potential billion dollar market would be trading even at cash level, let alone less than 33% cash within a month of registrational trial outcomes.

User Image Monsters_of_Swing Posted - 3 days ago

$SPRB

User Image Rohtan Posted - 3 days ago

$SPRB looks like it is heading low .40s before it starts going up again.

User Image keokeostwiz Posted - 3 days ago

$SPRB Every extension of results timeline enables SPRB to adjust dosage levels and adjust test protocols to best meet subjects requirements by the time Dec 21 arrives they should be able to manipulate results to meet acceptable test barometers.....additional time only favors a positive result as a maximum of varying doses and protocols will be completed.....in the meantime MM continues to manipulate price implementing stop loss raids ensuring retail exit and institutional hoarding of cheap shares.....there is no better example of patience foretelling profits......JMO

User Image Monsters_of_Swing Posted - 3 days ago

closely watching undervalued biotec opportunities $ANTX $BOLT $SPRB adding on further weakness

User Image vaselineguy Posted - 3 days ago

$SPRB positive news or ramen every night for good

Analyst Ratings
HC Wainwright & Co. Neutral Aug 19, 24
RBC Capital Sector Perform Aug 13, 24
Oppenheimer Outperform Jun 13, 24
HC Wainwright & Co. Neutral Jun 5, 24
HC Wainwright & Co. Neutral May 14, 24
RBC Capital Sector Perform Mar 14, 24
HC Wainwright & Co. Neutral Mar 14, 24
Leerink Partners Market Perform Mar 14, 24
JMP Securities Market Outperform Mar 14, 24